<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Surgery: Depression and Dysthymia Topic Collection</title>
    <link>http://archsurg.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 06 Feb 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Wed, 20 Feb 2013 15:44:17 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archsurg.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archsurg.jamanetwork.com</webMaster>
    <item>
      <title>Parathyroidectomy, Elevated Depression Scores, and Suicidal Ideation in Patients With Primary Hyperparathyroidism Results of a Prospective Multicenter Study  Parathyroidectomy and Elevated Depression Scores </title>
      <link>http://archsurg.jamanetwork.com/article.aspx?articleID=1379764</link>
      <pubDate>Fri, 01 Feb 2013 00:00:00 GMT</pubDate>
      <author>Weber T, Eberle J, Messelhäuser U, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To assess anxiety and depression symptoms, suicidal ideation, and health-related quality of life (HRQOL) in a large series of consecutive patients with primary hyperparathyroidism (pHPT) before and after parathyroidectomy.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;This prospective multicenter study investigated preoperative and postoperative depression, anxiety, suicidal ideation, and HRQOL in patients with pHPT and compared these variables with a control group with nontoxic thyroid nodules.&lt;div class="boxTitle"&gt;Patients&lt;/div&gt;The study included 194 patients with pHPT and 186 control subjects.&lt;div class="boxTitle"&gt;Main Outcome Measures&lt;/div&gt;Depression was evaluated with the Hospital Anxiety and Depression Scale (HADS) and the Patient Health Questionnaire–9, which also assessed suicidal ideation. Anxiety was evaluated with the HADS. Health-related quality of life was measured with the 36-Item Short Form survey.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Parathyroidectomy achieved a 98% cure rate. Preoperatively, severe depression (HADS score ≥11) was seen in 20% of the pHPT group and 9% of the control group. The Patient Health Questionnaire–9 detected moderate to severe depression in 17% of the patients with pHPT and 7% of the control subjects. Patients with pHPT had higher HADS anxiety scores (mean, 7.7) than control subjects (P &lt; .01) or the German normative sample (P &lt; .001). Compared with control subjects, patients with pHPT had significantly lower 36-Item Short Form survey preoperative physical and mental health summary scores (42.7 vs 49.5 and 41.2 vs 46.8, respectively; P = .001 for both comparisons). At 12 months follow-up, depression and anxiety decreased significantly in patients with pHPT; the prevalence of suicidal ideation was more than halved from the baseline (10.7% vs 22%; P = .008). Both physical and mental health scores (45.7 and 47.7, respectively) improved in patients with pHPT (P &lt; .001 each) but not in control subjects.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;Depression, anxiety, and decreased HRQOL appear to be related to pHPT. Successful parathyroidectomy seems to reduce psychopathologic symptoms and improve HRQOL in this setting.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">148</prism:volume>
      <prism:number xmlns:prism="prism">2</prism:number>
      <prism:startingPage xmlns:prism="prism">109</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">115</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/2013.jamasurg.316</prism:doi>
      <guid>http://archsurg.jamanetwork.com/article.aspx?articleID=1379764</guid>
    </item>
  </channel>
</rss>